Opportunities and challenges in the development of kinase inhibitor therapy for cancer
Open Access
- 15 December 2003
- journal article
- review article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 17 (24) , 2998-3010
- https://doi.org/10.1101/gad.1152403
Abstract
No abstract availableThis publication has 85 references indexed in Scilit:
- Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinaseProceedings of the National Academy of Sciences, 2003
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003
- Prognostic Value ofKITMutation Type, Mitotic Activity, and Histologic Subtype in Gastrointestinal Stromal TumorsJournal of Clinical Oncology, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS)Annals of Hematology, 1993
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991